Cargando…
P16 Expression in Human Breast Carcinoma and its Relationship to Clinicopathological Parameters
BACKGROUND: p16 is a cyclin-dependent kinase inhibitor and a cardinal regulator of the cell cycle. The relationship between p16 overexpression and poor prognosis of breast cancer has been reported in some studies. This study aimed to evaluate p16 expression in breast cancer in comparison to normal b...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10410420/ https://www.ncbi.nlm.nih.gov/pubmed/37564443 http://dx.doi.org/10.4103/abr.abr_180_22 |